Back to Search
Start Over
WTAP and m 6 A-modified circRNAs modulation during stress response in acute myeloid leukemia progenitor cells.
- Source :
-
Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2024 Jun 23; Vol. 81 (1), pp. 276. Date of Electronic Publication: 2024 Jun 23. - Publication Year :
- 2024
-
Abstract
- N <superscript>6</superscript> -methyladenosine (m <superscript>6</superscript> A) is one of the most prevalent and conserved RNA modifications. It controls several biological processes, including the biogenesis and function of circular RNAs (circRNAs), which are a class of covalently closed-single stranded RNAs. Several studies have revealed that proteotoxic stress response induction could be a relevant anticancer therapy in Acute Myeloid Leukemia (AML). Furthermore, a strong molecular interaction between the m <superscript>6</superscript> A mRNA modification factors and the suppression of the proteotoxic stress response has emerged. Since the proteasome inhibition leading to the imbalance in protein homeostasis is strictly linked to the stress response induction, we investigated the role of Bortezomib (Btz) on m <superscript>6</superscript> A regulation and in particular its impact on the modulation of m <superscript>6</superscript> A-modified circRNAs expression. Here, we show that treating AML cells with Btz downregulated the expression of the m <superscript>6</superscript> A regulator WTAP at translational level, mainly because of increased oxidative stress. Indeed, Btz treatment promoted oxidative stress, with ROS generation and HMOX-1 activation and administration of the reducing agent N-acetylcysteine restored WTAP expression. Additionally, we identified m <superscript>6</superscript> A-modified circRNAs modulated by Btz treatment, including circHIPK3, which is implicated in protein folding and oxidative stress regulation. These results highlight the intricate molecular networks involved in oxidative and ER stress induction in AML cells following proteotoxic stress response, laying the groundwork for future therapeutic strategies targeting these pathways.<br /> (© 2024. The Author(s).)
- Subjects :
- Humans
Bortezomib pharmacology
Cell Line, Tumor
Reactive Oxygen Species metabolism
RNA Splicing Factors metabolism
RNA Splicing Factors genetics
Cell Cycle Proteins metabolism
Cell Cycle Proteins genetics
Neoplastic Stem Cells metabolism
Neoplastic Stem Cells drug effects
Neoplastic Stem Cells pathology
Heme Oxygenase-1 metabolism
Heme Oxygenase-1 genetics
Protein Serine-Threonine Kinases
Intracellular Signaling Peptides and Proteins
RNA, Circular genetics
RNA, Circular metabolism
Leukemia, Myeloid, Acute genetics
Leukemia, Myeloid, Acute pathology
Leukemia, Myeloid, Acute metabolism
Leukemia, Myeloid, Acute drug therapy
Adenosine analogs & derivatives
Adenosine metabolism
Adenosine pharmacology
Oxidative Stress drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1420-9071
- Volume :
- 81
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Cellular and molecular life sciences : CMLS
- Publication Type :
- Academic Journal
- Accession number :
- 38909325
- Full Text :
- https://doi.org/10.1007/s00018-024-05299-9